InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.69
(
-1.57%
)
US TECH 100
16,926.80
(
-2.21%
)
Dow Jones
37,815.92
(
-1.49%
)
Brent Oil
85.59
(
-0.36%
)
Bitcoin
60,187.22
(
-0.68%
)
Post# of 423726
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sharinky

Send PM Follow Ignore
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

sharinky

Re: MontanaState83 post# 292975

Thursday, 08/27/2020 1:49:17 PM

Thursday, August 27, 2020 1:49:17 PM

Post# of 423726
If AMRN does not have to use coupon to reduce the copay, this is good news for AMRN and their shareholders as Net Revenue per script will increase. Also, with the lower out of pocket for Vascepa, there is less advantage for a generic to be in the market.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!